ライフサイエンスコーパス: cavitary

1 take (ie, whether nodular, consolidative, or cavitary).

2 ar opacities, only three (19%) of which were cavitary.

3 ciated inflammation, but most lesions become cavitary.

4 who were subsequently cured, the location of cavitary and non-cavitary lesions at baseline and new le

5 an immunodeficiency virus (non-HIV)-infected cavitary and noncavitary TB patients and from HIV-infect

6 vo bacteria that elicit antibodies differ in cavitary and noncavitary TB.

7 Congenital cavitary anomalies of the optic disc, including typical

8 be promising biomaterials for injection into cavitary brain lesions to recruit endogenous NPCs and en

9 out chemotactic cues and structural support, cavitary brain lesions typically fail to recruit endogen

10 M. bovis infections generated cavitary CFU counts of 10(6) to 10(9) bacilli, while non

11 TB patients with both a positive smear and a cavitary chest radiograph were more likely to have TB in

12 s (81.8%laparotomy, 18.2% sternotomy) before cavitary closure.

13 hial thickening and inflammation linking non-cavitary consolidative lesions to cavities were observed

14 eased mortality by 68%, infarct size by 40%, cavitary dilation by 26%, and diastolic stress by 70%.

15 healed infarct, foci of myocardial scarring, cavitary dilation, and impaired ventricular performance.

16 ging studies of 22 consecutive patients with cavitary disc maculopathy evaluated by a single surgeon

17 Rates of previous treatment (56%) and cavitary disease (61%) were high.

18 strains (L1.1.1.1) that was associated with cavitary disease (OR 2.49, 1.11-5.59, p=0.027) and treat

19 tely 50% of non-AIDS patients had upper-lobe cavitary disease and 50% had nodular bronchiectasis.

20 was less effective for MAC-PD patients with cavitary disease and a history of chronic obstructive pu

21 L11 compared to those with unilateral or non-cavitary disease and also exhibited a significant positi

22 Patients with both cavitary disease and highly positive sputum smear had a

23 evel transmission of strains associated with cavitary disease and treatment failure using terminal br

24 associated with relevant clinical outcomes (cavitary disease and treatment failure) by calculating o

25 due to MAC whereas patients with upper lobe cavitary disease are usually infected with only a single

26 including comorbidities, previous treatment, cavitary disease at conversion, low body mass index (BMI

27 PTB individuals with bilateral or cavitary disease displayed significantly elevated levels

28 (OR, 5.07; 95% CI, 1.73-14.9; P = .003), and cavitary disease in the absence of directly observed the

29 th M. bovis results in chronic, progressive, cavitary disease leading to death.

30 em risk score (HIV status, smear grade, sex, cavitary disease status, body mass index, and Month 2 cu

31 g use, and a history of incarceration and/or cavitary disease were predictors of clustering of high-c

32 collected from nine patients with upper lobe cavitary disease who were younger (mean age 52 yr), pred

33 ysis of the PET region of interest predicted cavitary disease with 100% sensitivity and 76% specifici

34 lysis of the CT region of interest predicted cavitary disease with 83.3% sensitivity and 76.9% specif

35 lled 72 patients with tuberculosis (27% with cavitary disease) and 109 of their child household conta

36 ifferences in patient characteristics (e.g., cavitary disease).

37 Fifty-nine participants, 88% with cavitary disease, 20% HIV-positive, 16 with isoniazid-se

38 other animals, two had chronic, progressive cavitary disease, a phenotype usually seen only with M.

39 Cavitary disease, BMI < 18.5, hepatitis C, prior treatme

40 Positive sputum smear and cavitary disease, correlates of disease burden, were ass

41 l models of tuberculosis (TB) rarely develop cavitary disease, limiting their value for assessing the

42 Those with cavitary disease, low BMI, hepatitis C, prior treatment

43 In patients with smear-positive and/or cavitary disease, macrophages or polymorphonuclear leuko

44 for patients with baseline drug resistance, cavitary disease, or HIV infection.

45 to its association with smear positivity and cavitary disease, suggesting that its influence on TB dy

46 ically linked mutations and outcomes such as cavitary disease, treatment failure, and transmission po

47 notypes were identified in the patients with cavitary disease, with only 1 of 9 (11%) having two or m

48 sults: Among 157 participants, 125 (80%) had cavitary disease.

49 d a body mass index <18.5 kg/m2, and 51% had cavitary disease.

50 h bronchiectasis and 27 (53%) had upper lobe cavitary disease.

51 at elicits antibodies during noncavitary and cavitary disease.

52 sera from a subset of patients with advanced cavitary disease.

53 a from TB patients with early noncavitary or cavitary disease.

54 acid-fast bacilli sputum smears and 43% had cavitary disease; at study entry, 35% remained smear pos

55 Having noncavitary, compared with cavitary, disease increased culture response by 4.0 time

56 ng normal and abnormal beats with the use of cavitary electrograms measured with a noncontact multiel

57 The feasibility of measuring cavitary electrograms using a noncontact probe and recon

58 At histopathologic analysis, focal cavitary enlargement with at least doubling of the ureth

59 The "cavitary" form of retinoblastoma has historically demons

60 sease that develops changes, with increasing cavitary formation and parenchymal tissue destruction.

61 , increased number of involved lung areas or cavitary formation.

62 myopathy in 3 siblings, characterized by mid-cavitary hypertrophy and restrictive physiology.

63 al tuberculosis (TB), whether noncavitary or cavitary, is the late stage of a chronic disease process

64 ng Mycobacterium tuberculosis recovered from cavitary isolates compared with paired sputum isolates s

65 ing the pathway for fluid migration from the cavitary lesion into and under the retina.

66 Immunosuppression, pulmonary disease, and cavitary lesion on chest radiographs were significantly

67 a risk factor for shorter survival, while a cavitary lesion on initial chest film and institution of

68 Surgical resection of the patient's solitary cavitary lesion was done as adjunctive treatment, and a

69 = 0.61), consolidative opacities (k = 1.00), cavitary lesions (k = 1.00), effusion (k = 0.64), mucus

70 ntly cured, the location of cavitary and non-cavitary lesions at baseline and new lesions at week 4 o

71 Patients who have stage I NSCLC with cavitary lesions have an adverse prognosis and are likel

72 The presence of cavitary lesions in patients with tuberculosis poses a s

73 omography (CT) to predict the development of cavitary lesions in rabbits.

74 Findings related to cavitary lesions including the pattern, number, size of

75 Seventy-one (70%) of the cases had cavitary lesions on chest radiograph, and 94 (92%) had s

76 -positive and culture-positive specimens and cavitary lesions on chest radiograph; both died of MDR T

77 toms, more extrapulmonary disease, and fewer cavitary lesions on chest radiographs.

78 After 8 weeks of ATT, cavitary lesions on X-ray (7, 5.3% vs 18, 12.9%; relativ

79 ranulomas with the potential to develop into cavitary lesions that aids bacterial escape into the air

80 The size of cavitary lesions was reduced in all patients, 2 months a

81 e successfully treated, 161 primarily apical cavitary lesions were identified at baseline.

82 Weight loss and cavitary lesions were more common (P< .01 for both compa

83 Cavitary lesions were significantly associated with shor

84 Cavitary lesions were significantly more common in squam

85 lin sparing U-fibers, axonal disruption, and cavitary lesions without inflammation.

86 ther variables in the model, the presence of cavitary lesions, acid-fast bacillus smear positivity, a

87 rn densities, macro-nodules, consolidations, cavitary lesions, ground-glass opacities, and miliary no

88 the progression of microcavities into large cavitary lesions, in part via a mechanism involving the

89 Patients with cavitary lesions, irrespective of drug choice, have an i

90 se boundaries by preventing the formation of cavitary lesions, mediated in part by Spp1-regulated pha

91 ctions at 33 weeks were associated with more cavitary lesions.

92 We report a case of cavitary lung abscess caused by a Capnocytophaga species

93 On further stratification, cavitary lung disease (P < 0.0001 for interaction) and s

94 f a woman presenting with bronchiectasis and cavitary lung disease associated with nontuberculous myc

95 ts only when they are smear-negative or lack cavitary lung disease.

96 onary emboli with 27 (93.1%) patients having cavitary lung lesions before the procedure.

97 ally resistant to infection but may manifest cavitary lung lesions.

98 This unique cavitary model provides a reliable animal model to study

99 10 days; P = .0615), increased frequency of cavitary necrosis at follow-up CT (seven of seven [100%]

100 se illness and may herald the development of cavitary necrosis in children with pneumonia.

101 ntensive care unit, length of hospital stay, cavitary necrosis in the lung at follow-up CT, and frequ

102 At histopathologic examination, diffuse cavitary necrosis was present in resected lobes in two p

103 All emergent trauma and nontrauma cavitary operations over a 5-year period (January 2010-D

104 intraretinal barrier to fluid migration from cavitary optic disc anomalies can be safely achieved in

105 The peculiar features of cavitary optic disc maculopathy can be explained only by

106 Cavitary optic disc maculopathy develops when fluctuatin

107 Children with tuberculosis, especially cavitary or laryngeal tuberculosis, should be considered

108 new lesions at week 4 of treatment suggest a cavitary origin of disease and bronchial spread through

109 CT scan findings were compared for cavitary, parenchymal, and non-parenchymal disorders.

110 similar to those of patients with MDR-TB for cavitary, parenchymal, and non-parenchymal lung characte

111 atous lesions in the peribronchial region or cavitary peripheral disease in smokers.

112 Aspergillus fumigatus causes chronic cavitary pulmonary aspergillosis (CCPA) and allergic bro

113 lower zones of the lungs, whereas infectious cavitary pulmonary disease develops at the lung apices.

114 novel follow-up therapy in patients without cavitary pulmonary disease who develop hepatotoxicity du

115 ndicated in almost all patients with chronic cavitary pulmonary infections, chronic invasive and gran

116 enzymes in human necrotic, nonnecrotic, and cavitary pulmonary tuberculosis (TB) lesions.

117 2% vs 33% for positive smear only vs 44% for cavitary radiograph only vs 37% for neither characterist

118 s in water at a micromolar level, based on a cavitary recognition process.

119 case series of all patients presenting with cavitary retinoblastoma between August 2014 and January

120 Eight cavitary retinoblastoma tumors in 6 eyes of 4 patients w

121 purpose was to report treatment response of cavitary retinoblastoma tumors to IAC.

122 Patients presenting with cavitary retinoblastoma who were treated with IAC.

123 Treatment with IAC results in regression of cavitary retinoblastoma, often with greater reduction in

124 ercentage points in Senegal) and in baseline cavitary status (P=0.04 for interaction) and body-mass i

125 phenotype characterized by the formation of cavitary structures.

126 high rates of multidrug resistance (12%) and cavitary TB (80%).

127 T-CT in experimentally infected rabbits with cavitary TB and confirmed using postmortem mass spectrom

128 Strategies targeting patients with cavitary TB have the potential to improve cure rates and

129 Since cavitary TB is associated with higher sputum bacillary l

130 contacts and contacts to highly smear(+) or cavitary TB patients were most likely to be TST(+).

131 r set of antigens is recognized primarily by cavitary TB patients.

132 igens recognized during both noncavitary and cavitary TB will enhance the sensitivity of antibody det

133 iunique region antibodies appear only during cavitary TB.

134 ecognized by antibodies from noncavitary and cavitary tuberculosis (TB) patients and (ii) to determin

135 animals, the rabbit is the only one in which cavitary tuberculosis can be readily produced.

136 Cavitary tuberculosis is difficult to cure and constitut

137 xygenase orthologue, ALOX12, is expressed in cavitary tuberculosis lesions; the abundance of its prod

138 Rabbits with established cavitary tuberculosis received the study drugs.

139 luding acute flares of rheumatoid arthritis, cavitary tuberculosis, acute myocardial infarction, and

140 describe and analyze the complete course of cavitary tuberculosis, produced by aerosolized virulent

141 the Marshall Islands in 1996, had bilateral cavitary tuberculosis.

142 One hundred percent of the cavitary tumors regressed (8/8 tumors, in 6/6 eyes), and

143 ges in wall thickness, chamber diameter, and cavitary volume were 41, 58, and 48% smaller in infarcte